Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Grey Wolf Animal Health Corp V.WOLF

Grey Wolf Animal Health Corp. is a Canadian diversified animal health company. The Company markets a portfolio of products that meets the unmet needs of veterinarians, clinics and pets. The Company operates two business units: Animal Health business unit and Pharmacy business unit. The Animal Health business unit focuses on sourcing, in-licensing, acquiring, and commercializing branded and generic pharmaceutical, nutraceutical, and consumable products for use in veterinary clinics across Canada. The Pharmacy business unit compounds pharmaceuticals, primarily for animal and human use, all based on prescriptions received from veterinarians, physicians, and patients. Its product categories include companion animals and equine health. The companion animal product category includes pharmaceuticals, wound care, nutraceuticals and disposables. Its equine health products include SUCCEED Digestive Conditioning Program, SUCCEED Equine Fecal Blood Test and Equi-Tape.


TSXV:WOLF - Post by User

User Avatar Image
(1928)
•••
  • Possibleidiot01X
Post by Possibleidiot01on Oct 31, 2024 7:51pm
92 Views
Post# 36291619

Competition Bureau

Competition Bureau

Competition Bureau recommends increasing competition in the sale of pet medication


News provided by

Competition Bureau

Oct 30, 2024, 14:30 ET


Mandating the supply of pet medication to pharmacists would improve competition and consumer choice.

GATINEAU, QC, Oct. 30, 2024 /CNW/ - In recent years, more Canadians have brought pets into their homes. But Canadians' choice of where to fill their pet's prescriptions is often limited to veterinary offices – which can mean fewer options and higher prices.

Today, the Competition Bureau has published an analysis of the pet pharmaceutical sector, titled Pets, vets and meds: The case for more competition. It examines the business practice in Canada of "exclusive distribution," where pharmaceutical manufacturers sell only to distributors, and distributors sell only to veterinarians.

 

The Bureau's analysis makes one recommendation: for provincial and territorial governments to consider mandating the supply of pet medications to pharmacists. Allowing pharmacists to enter the market has the potential to increase convenience and give Canadian pet owners more choice at competitive prices.

 

The analysis is based on research and interviews with a wide range of industry stakeholders across Canada, including veterinarians, pharmacists, regulatory colleges, provincial agencies, professional associations and animal owners associations.

Quotes

"As costs for pet care have increased, Canadians are concerned about affordability and availability of services. Mandating the supply of pet medications to pharmacists would improve competition. We are encouraging provincial pet healthcare regulators to apply a competition lens when evaluating what is best for their jurisdictions."

Matthew Boswell,
Commissioner of Competition

Quick facts



<< Previous
Bullboard Posts
Next >>